Health4 hours ago
Jan Stahlberg Expands Stake in DiaMedica Therapeutics with Major Purchase
Major shareholder Jan Stahlberg has significantly increased his investment in DiaMedica Therapeutics, Inc. (NASDAQ: DMAC) by acquiring 59,788 shares on August 22, 2023. The shares were...